Mepfarma India Private Limited

Mepfarma India Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24232CH2012PTC034097 Incorporated 20 September 2012 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Micro
Revenue · FY 2025
₹3.18 Cr
▼ 6% YoY
Net profit · FY 2025
₹7.86 Lakh
Net margin 2.5%
EBITDA · FY 2025
₹18.34 Lakh
EBITDA margin 5.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹20 Lakh
Issued & subscribed
Open charges
₹1.04 Cr
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings

About Mepfarma India Private Limited

Data last updated:

Mepfarma India Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 September 2012 and has been in existence for over 14 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PTC034097. Its GSTIN is 06AAICM2315D1ZY (Haryana). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Vinay Chadha (Managing Director) and Ramandeep Garg.

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 270 Ground Floor Motor Market Manimajra, Chandigarh, India – 160101.

As per the financials filed for FY 2025, the company reported a revenue of ₹3.18 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹7.86 Lakh (net margin 2.5%) and EBITDA of ₹18.34 Lakh (EBITDA margin 5.8%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 3% over five years.

As per MCA filings, the company has open charges of ₹1.04 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.

Mepfarma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0004627). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mepfarmaindia.com.

Company details

CIN U24232CH2012PTC034097
Registration Number 034097
Incorporation Date 20 September 2012
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-HR-13-0004627

Recognitions & Rankings of Mepfarma India

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-HR-13-0004627

Contact details

Mepfarma India Private Limited's registered office is in Chandigarh, Chandigarh. Its website is mepfarmaindia.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Scf 270 Ground Floor Motor Market Manimajra, Chandigarh, India – 160101
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Mepfarma India Private Limited, buy the company report.

Comprehensive company report
Mepfarma India Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Mepfarma India is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Mepfarma India Private Limited, buy the company report.

Financials of Mepfarma India Private Limited

FY 2025 filings available

Mepfarma India Private Limited reported revenue of ₹3.18 Cr (down 6% YoY) for FY 2025.

Revenue · FY 2025
₹3.18 Cr ▼ 6%
Net profit · FY 2025
₹7.86 Lakh margin 2.5%
EBITDA · FY 2025
₹18.34 Lakh margin 5.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 5%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 14%
3 years · compounded
▼ 6%
5 years · compounded
▼ 3%

Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 6% fall in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹18.34 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹7.86 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.8%
Net Profit Margin2.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Mepfarma India Private Limited, buy the company report.

Board of directors of Mepfarma India Private Limited

Mepfarma India has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Vinay ChadhaManaging Director20 Sep 201214 Years 2 MonthsCurrent
Ramandeep GargDirector20 Sep 201214 Years 2 MonthsCurrent

Peer comparison

Mepfarma India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Rachil Remedies Pvt Ltd₹3.19 Cr (FY 2025)-54.0%Agra, Uttar Pradesh, India
Mepfarma India Private Limitedthis company₹3.18 Cr (FY 2025)₹7.86 Lakh2.5%-6.0%Chandigarh, India
Babuline Pharma Private Limited₹3.18 Cr (FY 2025)-13.0%Mumbai, Maharashtra, India
Biostella Projects (OPC) Private Limited₹3.18 Cr (FY 2025)426.0%Karimganj, Assam, India
Yuzderm Pharmaceuticals Private Limited₹3.17 Cr (FY 2025)61.0%Mumbai, Maharashtra, India

To see the full peer comparison of Mepfarma India Private Limited, buy the company report.

Auditor

Mepfarma India Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
VIKAS SANJIV & ASSOCIATESFY 2023018361N

Shareholding

The shareholding of Mepfarma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Mepfarma India Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.04 Cr
Satisfied charges
None
Breakdown by lending institutions
Others₹1.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Jul 2019100279595Others₹1.04 CrOpen

Total charge records: 1 View all charges

MSME payment delays

Mepfarma India Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 34 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 8)

SupplierAmount dueDue sinceReported on
Ultra Drugs Private Limited
NDB Healthcare So-Solan (H.P.)
C.B.Healthcare-Nalagarh (H.P)
an individual supplier
Blessings Healthcare Private Limited

To see the full MSME payment records of Mepfarma India Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Mepfarma India has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
06AAICM2315D1ZYHaryanaActive12 Sep 2019

To see the full GST registrations and return filing status of Mepfarma India Private Limited, buy the company report.

Recent activity

Mepfarma India Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Vinay Chadha ceased to be Director on 01 Apr 2013.

AGM
Mepfarma India Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Mepfarma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Others amounted to Rs. 103.75 Lakh with Charge ID 100279595 was registered on 10 Jul 2019.
Ceased
Vinay Chadha ceased to be Director.
Appointed
Ramandeep Garg was appointed as Director.
Appointed
Vinay Chadha was appointed as Managing Director.
Incorporation
20 Sep 2012
Mepfarma India Private Limited was registered on 20 Sep 2012 with Roc Chandigarh & aged 14 years 2 months as per MCA records.

Frequently asked questions

Mepfarma India is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 September 2012 (14+ years old) and is registered under CIN U24232CH2012PTC034097.

Mepfarma India has 2 current directors:

The latest financial statements of Mepfarma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Mepfarma India is 06AAICM2315D1ZY, registered in Haryana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Mepfarma India is U24232CH2012PTC034097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Mepfarma India has 2 court cases on record: 2 filed against it. 1 is pending.

Mepfarma India was incorporated on 20 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Mepfarma India by revenue are Rachil Remedies Pvt Ltd, Babuline Pharma Private Limited, Biostella Projects (OPC) Private Limited, Yuzderm Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Vinay Chadha ceased to be Director on 01 Apr 2013. Ramandeep Garg was appointed as Director on 20 Sep 2012. Vinay Chadha was appointed as Managing Director on 20 Sep 2012.

Yes, Mepfarma India is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-13-0004627).

Mepfarma India has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 34 overdue payments to 8 micro and small suppliers. The latest return was filed on 23 May 2019.

Mepfarma India can be reached through the website mepfarmaindia.com. Its registered office is in Chandigarh, India.